Crops and Products

Enecta specialises in the in the development of products based on cannabinoidsin particular CBD. The range of solutions offered, with different concentrations of cannabinoids, allows the choice of the right product for every need. The experience developed by Enecta in the production of genetics, cultivation and production processes has allowed Enecta to consolidate its position on the international market for the marketing of Cannabis Sativa L. and its derivative products.

Crops and Products

Enecta specialises in the in the development of products based on cannabinoidsin particular CBD. The range of solutions offered, with different concentrations of cannabinoids, allows the choice of the right product for every need. The experience developed by Enecta in the production of genetics, cultivation and production processes has allowed Enecta to consolidate its position on the international market for the marketing of Cannabis Sativa L. and its derivative products.

Do you want to know more about the quality of our products and crops?

GO TO OUR DEDICATED PAGE

Would you like to get our
guide to cultivation?

Contact us now: christian@enecta.com

 

Proprietary Genetics

The goal that has guided Enecta from day one is to make effective, quality products.
This principle has led us over the years to structure our production process towards an ever greater and more qualified integration of the supply chain, and today we are one of the very few companies in Europe to follow the process from start to finish, from seed to extract.
 
The quality of the seed and the genetics is the real watershed for successful cultivation and final harvest quality. Using poor quality or inadequately controlled genetics would result in an uneven final cannabinoid profile and a final yield below expectations. On the contrary, a good seed will guarantee stability and security in terms of performance and a product of suitable quality.
 
It is for this reason that Enecta works in partnership with Canvasalus, for the development and registration of new varieties of Cannabis. To date, Enecta and Canvasalus have patented and registered 14 different cannabis varieties at the Community Plant Variety Office (the control agency that registers plant varieties among EU Member States) with high CBD or CBG content.
 
Among them, two varieties, Enectaliana and Enectarol, have been awarded the Certified Seed Tag - for marketing in Europe. Enectarol is also registered with the USDA (United States Department of Agriculture) and can be legally produced and sold in the US.
 

Cultivations

Green Valley is the official partner farm of Enecta in Cannabis cultivations aimed at the production of CBD and other non-psychotropic cannabinoids. Starting in 2017, Green Valley has started cultivations in Abruzzo (8 hectares in the province of L'Aquila), and in 2018, it has developed, in partnership with the Poiana Cooperative, in the province of Treviso, one of the largest hemp cultivation in Europe.

In 2017, Enecta and Green Valley conducted a research project on the optimization of agronomic techniques for the cultivation of Cannabis sativa L. together with CREA-CI, the Research Center of Cereal Growing and Industrial Crops. Thanks to this work, new models of mechanization of the phases of cultivation, harvesting, handling and storage have been developed, for the yield, speed and safety of the hemp harvest.

These techniques will soon be available to farmers who wish to collaborate with Green Valley in the cultivation of cannabis with high quality standards. Cultivation takes place in selected fields without the use of pesticides, and following the guidelines of Good Agricultural and Collection Practices (GACP). In addition, constant monitoring of contaminants is carried out according to the specifications of the European Pharmacopoeia.

Production

Enecta specializes in the development of cannabinoid-based products. The methods used maximize all the characteristics of effectiveness and safety to guarantee products of the highest quality and performance.

  • Raw material grown in Italy by GreenValley and other farms.
  • Partner of Italian pharmaceutical workshop at the forefront in the production process of cannabinoids
  • Instruction of an adequate quality assurance system based on the indications of GMP (Good Manufacturing Practices) and HACCP (Hazard Analysis and Critical Control Points) protocols. 
  • CBD: Main cannabinoid used
  • Third party certificate of compliance with EU GMP (Good Manufacturing Practices) Part II (ICH Q7) guidelines for the production process of Cannabidiol.
  • Developed the technique for production of Cannabigerol (CBG)
  • Production process ofadditional cannabinoidsunder investigation

Production

Enecta specializes in the development of cannabinoid-based products. The methods used maximize all the characteristics of effectiveness and safety to guarantee products of the highest quality and performance.

  • Raw material grown in Italy by GreenValley and other farms.
  • Partner of Italian pharmaceutical workshop at the forefront in the production process of cannabinoids
  • Instruction of an adequate quality assurance system based on the indications of GMP (Good Manufacturing Practices) and HACCP (Hazard Analysis and Critical Control Points) protocols. 
  • CBD: Main cannabinoid used
  • Third party certificate of compliance with EU GMP (Good Manufacturing Practices) Part II (ICH Q7) guidelines for the production process of Cannabidiol.
  • Developed the technique for production of Cannabigerol (CBG)
  • Production process of additional cannabinoids under investigation

Formulations

The experience developed by Enecta in the formulation and in the production of products containing cannabinoids has allowed Enecta to consolidate its position on the international market for the commercialization of Cannabis Sativa L. and its derivative products, some of which are used also to conduct studies clinical studies.

    • The manufacture of the products follows, as far as possible, the GMP principles and guidelines
    • Products full spectrum with high concentrations of phytocannabinoids
    • 99% CBD Crystals and 99% CBG Crystals
    • CBD oils with different percentages
    • Cosmetic formulations
    • Formulations with Terpeni
    • Capsules
    • Dyes

    In full spectrum formulations there are additional cannabinoids, CBG, CBDA, CBDV, CBN, and several terpenes, such as Myrcene, Limonene, α- and β-Pinene, β-Caryophyllene.

    Formulations

    The experience developed by Enecta in the formulation and in the production of products containing cannabinoids has allowed Enecta to consolidate its position on the international market for the commercialization of Cannabis Sativa L. and its derivative products, some of which are used also to conduct studies clinical studies.

    • The manufacture of the products follows, as far as possible, the GMP principles and guidelines
    • Products full spectrum with high concentrations of phytocannabinoids
    • 99% CBD Crystals and 99% CBG Crystals
    • CBD oils with different percentages
    • Cosmetic formulations
    • Formulations with Terpeni
    • Capsules
    • Dyes

    In full spectrum formulations there are additional cannabinoids, CBG, CBDA, CBDV, CBN, and several terpenes, such as Myrcene, Limonene, α- and β-Pinene, β-Caryophyllene.

    From a selected and selected seed to a convenient, safe and effective product.

    At Enecta, as one of the first to produce and distribute CBD extracts in Europe, we know how difficult it is to guarantee the highest quality at an affordable price for everyone. It is an effort that requires an integrated organisation that is able to manage the entire production process while ensuring efficiency in the raw material, the extraction process and quality control at every stage.

    THE PRODUCTION PROCESS
    OUR PRODUCTS

    Participate!

    If you have projects, ideas, want to share experiences, or give us suggestions on how to improve our impact on patients, communities, and the environment, contact us!

    Contact us at

    2 + 3 =